Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China.
Stock data | 2024 | Change |
---|---|---|
Price | $7.93 | N/A |
Market Cap | $3.23B | N/A |
Shares Outstanding | 406.80M | N/A |
Employees | 1.55K | N/A |